Disease Overview：Eczema（ECZ）
Eczema, or atopic dermatitis, is a chronic, relapsing inflammatory skin disorder characterized by pruritus, erythema, xerosis, lichenification, and vesiculopapular eruptions. It results from a complex interplay of epidermal barrier dysfunction—often linked to filaggrin gene mutations—and dysregulated immune responses involving Th2 cytokines (IL-4, IL-13, IL-31), T-cell infiltration, and environmental triggers such as allergens, irritants, and microbial dysbiosis. Diagnosis relies on clinical evaluation using validated criteria (e.g., Hanifin & Rajka), supplemented by patch testing, serum IgE quantification, and occasionally skin biopsy to exclude mimics like psoriasis or contact dermatitis. Management follows a stepwise approach: topical corticosteroids and calcineurin inhibitors for mild-to-moderate disease; systemic immunomodulators (cyclosporine, methotrexate) or biologics (dupilumab, tralokinumab) for severe cases; and rigorous emollient-based barrier repair protocols.
China offers distinct advantages for eczema treatment: its dermatology centers—especially tier-3 hospitals in Beijing, Shanghai, and Guangzhou—boast internationally trained specialists with extensive experience managing refractory atopic dermatitis and comorbid allergic conditions. Advanced modalities include narrowband UVB phototherapy, targeted biologic infusion programs, and AI-assisted severity scoring tools integrated into electronic health records. Clinical outcomes align with global benchmarks: over 85% of moderate-to-severe patients achieve EASI-75 improvement within 16 weeks on dupilumab regimens, per recent multicenter registry data. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising evidence-based protocols or regulatory compliance (NMPA-approved biologics, ISO-certified facilities).
As a dedicated medical tourism agency, we facilitate seamless access to these resources for international patients—handling hospital referrals, visa support, multilingual consultations, transparent itemized pricing, and end-to-end coordination from initial assessment to follow-up telemedicine.
Eczema: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Eczema (Dermatology)
Non-Surgical / Conservative / Medication Options
*Target criteria:* Mild-to-moderate atopic, contact, or nummular eczema; no systemic involvement or refractory flares.
- •Topical Therapy (First-line)
- Mid-potency steroids (e.g., mometasone 0.1% ointment): $12–$22/tube (30g) - Topical calcineurin inhibitors (tacrolimus 0.03% ointment): $28–$45/tube (30g)
- •Systemic Medications (Moderate-severe, steroid-dependent)
- Oral corticosteroids (prednisone 5 mg × 14-day taper): $5–$9/course - Cyclosporine (2.5–5 mg/kg/day, 3-month course): $180–$320/month
- •Diagnostic & Monitoring Fees
- Patch testing (standard 36-allergen panel): $42–$65 - Serum IgE + eosinophil count: $14–$21
Surgical / Procedural / Interventional Options
*Eligibility:* Severe, chronic, treatment-refractory eczema with lichenification, fissuring, or secondary infection unresponsive to ≥3 months *No surgical excision or ablation is indicated for eczema itself.*
- •Narrowband UVB Phototherapy (Standard Course: 24 sessions over 8–12 weeks)
- Full course (24 sessions): $265–$410 - Pre-treatment workup (skin exam, liver/kidney function, ophthalmologic slit-lamp exam *only if phototherapy planned*): $32–$48
- •Biologic Therapy (Dupilumab – subcutaneous injection)
- Maintenance (300 mg every 2 weeks): $710–$890/injection - Required pre-infusion labs (CBC, LFTs, HBV/HCV screening): $26–$39
Special / Complex Condition Management
- •Infantile Eczema (<2 years) with severe prurigo nodules:
- •Eczema Herpeticum (HSV superinfection):
- •Occupational Eczema with confirmed allergen:
Quick Selection Guide
- •Children <6 years, mild disease, budget-conscious: Start with emollients + low-potency topical steroids ($3–$8/tube) + $18 consult. Avoid biologics/phototherapy.
- •Adults, moderate chronic eczema, mid-range budget ($500–$2,000/year): Tacrolimus ointment + phototherapy course ($410) + quarterly follow-ups ($75/year).
- •Severe refractory adult eczema, comorbid asthma/allergic rhinitis, higher budget: Dupilumab ($8,500–$10,700/year) after confirming IgE elevation and negative HBV/HCV.
- •Elderly patients (>75), polypharmacy, renal impairment: Prioritize low-dose cyclosporine ($180/month) with monthly LFT monitoring ($12/test) over biologics or phototherapy.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Eczema Medical Vacation Packages
Curated transparent all-inclusive packages combining Eczema treatment with China top medical destinations:
